Clinical Trials
141 trialsA Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers
Neovia Oncology Ltd.
An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread
Bristol-Myers Squibb
RP-6306 in Patients With Advanced Cancer
Canadian Cancer Trials Group
An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers
Bristol-Myers Squibb
CCST2
Duke University
CheckMate 577
Bristol-Myers Squibb
A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors
Bristol-Myers Squibb
A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors
Agenus Inc.
Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort
Prescient Therapeutics, Ltd.
MATTERS
ElmediX
PCRSS
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer
Mayo Clinic
Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors
Akeso
Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors
Akeso
MSPD
Institut du Cancer de Montpellier - Val d'Aurelle
SHAPE
Duke-NUS Graduate Medical School
Videos for Advance Care Planning in Young Adults
Dana-Farber Cancer Institute
EMPallA
NYU Langone Health
The PediQUEST Response Intervention Study
Massachusetts General Hospital
TAX-TORC
Royal Marsden NHS Foundation Trust
ComPAKT
Royal Marsden NHS Foundation Trust
A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors
Bristol-Myers Squibb
A Phase 1 Study of LY2835219 In Participants With Advanced Cancer
Eli Lilly and Company
Psychosocial Intervention in Latino Patients with Advanced Cancer
University of Colorado, Denver
First-In-Human Study of EOS884448 in Participants with Advanced Cancers.
iTeos Therapeutics
Nutrition Assessment in Advanced Cancer Patients
West China Hospital
A Study of CFI-400945 Fumarate in Patients With Advanced Cancer
University Health Network, Toronto
Resilient Living Program for Patients With Advanced Cancer and Their Caregivers
Mayo Clinic
Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients
Bayer
Interactive Voice Response System in Advanced Cancer Patients
M.D. Anderson Cancer Center
Caregiver-Guided Pain Management Training in Palliative Care
Duke University
The Efficacy of Multisession Mindful Breathing in Symptom Reduction Among Patients With Advanced Cancers
University Malaysia Sarawak
Revie⊕
School of Health Sciences Geneva
Spirituality/Religiosity in Patients and Caregivers
M.D. Anderson Cancer Center
BAL
REHPA, The Danish Knowledge Centre for Rehabilitation and Palliative Care
Variation in Cancer Centers' End-of-Life Quality
Dartmouth-Hitchcock Medical Center
A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer
CASI pharmaceuticals, Inc.
FRACTION-RCC
Bristol-Myers Squibb
ADVISE
Bristol-Myers Squibb
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies
M.D. Anderson Cancer Center
Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers
Massachusetts General Hospital
A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)
Merck Sharp & Dohme LLC
Patient-centered Self-administered Acupressure for Fatigue Management in Chinese Advanced Cancer Patients
The University of Hong Kong
A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors
CStone Pharmaceuticals
LeY-CAR-T
Peter MacCallum Cancer Centre, Australia
DRIIV-1
Valerio Therapeutics
A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors
Bristol-Myers Squibb
A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors
Bristol-Myers Squibb
A Study of CS1003 in Subjects With Advanced Solid Tumors
CStone Pharmaceuticals
Early Palliative Care on Quality of Life of Patients With Advanced Pancreas Cancer
University of Manitoba